Alife Health says new research shows the promise of its artificial intelligence model to improve in vitro fertilization (IVF) outcomes, though its findings of increased egg yield and reduced usage of follicle stimulating hormone (FSH) in AI-supported decisions were not statistically significant.
Stim Assist, the focus of the observational postmarket study published 20 August in Nature’s Scientific Reports, considers a patient's...